Impact of Cannabis Use on Least Pain Scores Among African American and White Patients with Cancer Pain: A Moderation Analysis

References

• Institute of Medicine. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Washington, D.C.: National Academies Press; 2011.
   Google Scholar
• Anderson KO, Green CR, Payne R. Racial and ethnic disparities in pain: causes and consequences of unequal care. J Pain. 2009;10(12):1187–1204. doi:10.1016/j.jpain.2009.10.002
   PubMed Web of Science ®Google Scholar
• Cintron A, Morrison RS. Pain and ethnicity in the United States: a systematic review. J Palliat Med. 2006;9(6):1454–1473. doi:10.1089/jpm.2006.9.1454
   PubMed Web of Science ®Google Scholar
• Meghani SH, Byun E, Gallagher RM. Time to take stock: a meta-analysis and systematic review of analgesic treatment disparities for pain in the United States. Pain Med. 2012;13(2):150–174. doi:10.1111/j.1526-4637.2011.01310.x
   PubMed Web of Science ®Google Scholar
• Castel LD, Saville BR, Depuy V, Godley PA, Hartmann KE, Abernethy AP. Racial differences in pain during 1 year among women with metastatic breast cancer: a hazards analysis of interval-censored data. Cancer. 2008;112(1):162–170. doi:10.1002/cncr.23133
   Web of Science ®Google Scholar
• Jayadevappa R, Johnson JC, Chhatre S, Wein AJ, Malkowicz SB. Ethnic variation in return to baseline values of patient-reported outcomes in older prostate cancer patients. Cancer. 2007;109(11):2229–2238. doi:10.1002/cncr.22675
   Web of Science ®Google Scholar
• Meghani SH, Kang Y, Chittams J, McMenamin E, Mao JJ, Fudin J. African Americans with cancer pain are more likely to receive an analgesic with toxic metabolite despite clinical risks: a mediation analysis study. J Clin Oncol. 2014;32(25):2773–2779. doi:10.1200/JCO.2013.54.7992
   Web of Science ®Google Scholar
• Meghani SH, Thompson AM, Chittams J, Bruner DW, Riegel B. Adherence to analgesics for cancer pain: a comparative study of African Americans and whites using an electronic monitoring device. J Pain. 2015;16(9):825–835.
   PubMed Web of Science ®Google Scholar
• Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94(2):149–158. doi:10.1016/S0304-3959(01)00349-9
   PubMed Web of Science ®Google Scholar
• Meghani SH, Hanlon A, Bubanj J, Riegel B, Bruner D. Do self-reported analgesic barriers translate into objective analgesic adherence for cancer pain? J Pain. 2013;14(4):S38. doi:10.1016/j.jpain.2013.01.447
   Web of Science ®Google Scholar
• Meghani SH, Knafl GJ. Patterns of analgesic adherence predict health care utilization among outpatients with cancer pain. Patient Prefer Adherence. 2016;10:81–98. doi:10.2147/PPA.S93726
   PubMed Web of Science ®Google Scholar
• Bar-Lev Schleider L, Mechoulam R, Lederman V, et al. Prospective analysis of safety and efficacy of medical cannabis in large unselected population of patients with cancer. Eur J Intern Med. 2018;49:37–43. doi:10.1016/j.ejim.2018.01.023
   PubMed Web of Science ®Google Scholar
• Pergam SA, Woodfield MC, Lee CM, et al. Cannabis use among patients at a comprehensive cancer center in a state with legalized medicinal and recreational use. Cancer. 2017;123(22):4488–4497. doi:10.1002/cncr.30879
   PubMed Web of Science ®Google Scholar
• Turgeman I, Bar-Sela G. Cannabis use in palliative oncology: a review of the evidence for popular indications. Isr Med Assoc J. 2017;19(2):85–88.
   Web of Science ®Google Scholar
• Martell K, Fairchild A, LeGerrier B, et al. Rates of cannabis use in patients with cancer. Curr Oncol. 2018;25(3):219–225. doi:10.3747/co.25.3983
   PubMed Web of Science ®Google Scholar
• Lucas P, Walsh Z. Medical cannabis access, use, and substitution for prescription opioids and other substances: a survey of authorized medical cannabis patients. Int J Drug Policy. 2017;42:30–35. doi:10.1016/j.drugpo.2017.01.011
   PubMed Web of Science ®Google Scholar
• Meghani SH, Wool J, Davis J, Yeager KA, Mao JJ, Barg FK. When Patients Take Charge of Opioids: Self-Management Concerns and Practices Among Cancer Outpatients in the Context of Opioid Crisis. J Pain Symptom Manage. 2020;59(3):618–625.
   Google Scholar
• Boyaji S, Merkow J, Elman RNM, Kaye AD, Yong RJ, Urman RD. The role of cannabidiol (CBD) in chronic pain management: an assessment of current evidence. Curr Pain Headache Rep. 2020;24(2):4. doi:10.1007/s11916-020-0835-4
   PubMed Web of Science ®Google Scholar
• Anderson KO, Richman SP, Hurley J, et al. Cancer pain management among underserved minority outpatients: perceived needs and barriers to optimal control. Cancer. 2002;94(8):2295–2304. doi:10.1002/cncr.10414
   PubMed Web of Science ®Google Scholar
• Cleeland CS, Gonin R, Hatfield AK, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med. 1994;330(9):592–596. doi:10.1056/NEJM199403033300902
   PubMed Web of Science ®Google Scholar
• Cleeland CS. The brief pain inventory: user guide; 2009. Available from: https://www.mdanderson.org/documents/Departments-and-Divisions/Symptom-Research/BPI_UserGuide.pdf. Accessed July 28, 2021.
   Google Scholar
• Jensen MP, Wang W, Potts SL, Gould EM. Reliability and validity of individual and composite recall pain measures in patients with cancer. Pain Med. 2012;13(10):1284–1291. doi:10.1111/j.1526-4637.2012.01470.x
   PubMed Web of Science ®Google Scholar
• Ward SE, Carlson-Dakes K, Hughes SH, Kwekkeboom KL, Donovan HS. The impact on quality of life of patient-related barriers to pain management. Res Nurs Health. 1998;21(5):405–413. doi:10.1002/(SICI)1098-240X(199810)21:5<405::AID-NUR4>3.0.CO;2-R
   Web of Science ®Google Scholar
• Nicholas MK. The pain self-efficacy questionnaire: taking pain into account. Eur J Pain. 2007;11(2):153–163. doi:10.1016/j.ejpain.2005.12.008
   PubMed Web of Science ®Google Scholar
• Butler SF, Budman SH, Fernandez KC, et al. Development and validation of the current opioid misuse measure. Pain. 2007;130(1–2):144–156. doi:10.1016/j.pain.2007.01.014
   PubMed Web of Science ®Google Scholar
• Belcher SM, Watkins Bruner D, Hofmeister CC, Kweon J, Meghani SH, Yeager KA. Characterizing pain experiences: African American patients with multiple myeloma taking around-the-clock opioids. Clin J Oncol Nurs. 2020;24(5):538–546. doi:10.1188/20.CJON.538-546
   PubMed Web of Science ®Google Scholar
• Meghani SH, Rosa WE, Chittams J, Vallerand AH, Bao T, Mao JJ. Both race and insurance type independently predict the selection of oral opioids prescribed to cancer outpatients. Pain Manag Nurs. 2020;21(1):65–71. doi:10.1016/j.pmn.2019.07.004
   Web of Science ®Google Scholar
• Tringale KR, Huynh-le MP, Salans M, Marshall DC, Shi Y, Hattangadi-Gluth JA. The role of cancer in marijuana and prescription opioid use in the United States: a population-based analysis from 2005 to 2014. Cancer. 2019;125(13):2242–2251.
   Web of Science ®Google Scholar
• Satterlund TD, Lee JP, Moore RS. Stigma among California’s medical marijuana patients. J Psychoactive Drugs. 2015;47(1):10–17. doi:10.1080/02791072.2014.991858
   PubMed Web of Science ®Google Scholar
• Pacek LR, Mauro PM, Martins SS. Perceived risk of regular cannabis use in the United States from 2002 to 2012: differences by sex, age, and race/ethnicity. Drug Alcohol Depend. 2015;149:232–244. doi:10.1016/j.drugalcdep.2015.02.009
   PubMed Web of Science ®Google Scholar
• Hasin DS, Shmulewitz D, Sarvet AL. Time trends in US cannabis use and cannabis use disorders overall and by sociodemographic subgroups: a narrative review and new findings. Am J Drug Alcohol Abuse. 2019;45(6):623–643. doi:10.1080/00952990.2019.1569668
   PubMed Web of Science ®Google Scholar
• Chesney E, McGuire P, Freeman TP, Strang J, Englund A. Lack of evidence for the effectiveness or safety of over-the-counter cannabidiol products. Ther Adv Psychopharmacol. 2020;10:2045125320954992. doi:10.1177/2045125320954992
   Web of Science ®Google Scholar
• Dworkin RH, Turk DC, Farrar JT, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005;113(1–2):9–19. doi:10.1016/j.pain.2004.09.012
   PubMed Web of Science ®Google Scholar
• Dworkin RH, Turk DC, Wyrwich KW, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain. 2008;9(2):105–121. doi:10.1016/j.jpain.2007.09.005
   PubMed Web of Science ®Google Scholar
• Turk DC, Dworkin RH, Burke LB, et al. Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations. Pain. 2006;125(3):208–215. doi:10.1016/j.pain.2006.09.028
   Web of Science ®Google Scholar
• Administration FaD. Guidance for industry patient-reported outcome measures: use in medical product development to support labeling claims; 2009. Available from: https://www.fda.gov/media/77832/download. Accessed July 28, 2021.
   Google Scholar
• Markman JD, Gewandter JS, Frazer ME. Comparison of a pain tolerability question with the numeric rating scale for assessment of self-reported chronic pain. JAMA Netw Open. 2020;3(4):e203155. doi:10.1001/jamanetworkopen.2020.3155
   Web of Science ®Google Scholar